Manufacturing of amorphous pharmaceutical formulations can be complex and costly. KinetiSol is an elegantly simple manufacturing technology capable of high-throughput production of amorphous systems.
KinetiSol is based on a commercial plastics compounding process and was developed by DisperSol into a cGMP-compliant pharmaceutical technology. The KinetiSol pharmaceutical manufacturing process can be run from kiloton-commercial scale down to sub-10 gram batch sizes to accommodate the material-sparing needs of early drug development.
WHY USE KINETISOL ?
KinetiSol Fits In-Line with Existing Manufacturing Operations
- Solve formulating challenges no other technology can
- Create patent-protected compositions no other technology can
- Make higher-performing products